Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome.
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: In this study we sought to identify differences in risk factors and outcome of critically ill patients with Candida albicans and non-albicans candidemia. METHODS: Nonimmunosuppressed, nonneutropenic patients with candidemia diagnosed after intensive care unit (ICU) admission were included in a prospective observational study in a medical-surgical ICU at a tertiary academic hospital in Athens, Greece. RESULTS: During the study period (January 2001 to December 2005), 56 candidemia episodes in 1037 ICU admissions were included (5.4%). Of these patients, 36/56 (64.3%) had candidemia due to C. albicans and 20/56 (35.7%) due to non-albicans species (8/56 [14.3%] C. glabrata, 6/56 [10.7%] C. tropicalis, 3/56 [5.4%] C. parapsilosis, 1/56 [1.8%] C. lusitaniae, 1/56 [1.8%] C. krusei and 1/56 [1.8%] C. dubliniensis). Administration of glucocorticosteroids, central venous catheter placement, and preexisting candiduria were independently associated with candidemia due to C. non-albicans species (Odds ratio [OR]: 45.1, 95% confidence interval [CI]: 3.0-669.9; OR: 26.2, 95% CI: 2.1-334.8; and OR: 16.5, 95% CI: 1.6-173.9, respectively). The treatment response rate differed significantly between patients with C. albicans and patients with C. non-albicans bloodstream infections (29/36 [80.6%] vs 9/20 [45%], P = 0.006). Overall mortality was higher in patients with non-albicans species than C. albicans bloodstream infections (18/20 [90%] vs 19/36 [52.8%], P = 0.005). Multivariable logistic regression analysis revealed that candidemia due to non-albicans species was independently associated with death (OR: 6.7, 95% CI: 1.2-37.7). CONCLUSIONS: In the subset of critically ill nonimmunosuppressed patients, candidemia caused by non-albicans species occurred more frequently in those with medical devices or receiving steroids. Candidemia due to non-albicans species was also associated with higher mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These species exhibit higher levels of resistance to antifungal medications and might be associated with higher mortality than C. albicans (18).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [18]
In the citing paper
“Compared with C. albicans, these species more frequently exhibit antifungal resistance and might be associated with higher mortality rates for patients with candidemia (12–14).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — 10 Sites, United States, 2017–2021 (2025) · cites this paper as [12]
In the citing paper
“a prospective study in a medical-surgical ICU suggested that candidemia due to non-albicans species was associated with higher mortality [16].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [16]
Citations
Cites
Nosocomial infections in medical intensive care units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., & Gaynes, R. P. (1999) · Critical Care Medicine · doi:10.1097/00003246-199905000-00020 · Cited by 1,565
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Pappas, P. G., Rex, J. H., Lee, J., Hamill, R. J., Larsen, R. A., Powderly, W., Kauffman, C. A., Hyslop, N., Mangino, J. E., Chapman, S., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376906 · Cited by 845
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
Krcmery, V., & Barnes, A. J. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1151 · Cited by 733 · cited 2×
“albicans, varying from 15% to 35%.(11) However, there are very few”
BackgroundTrick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Tortorano, A. M., Peman, J., Bernhardt, H., Klingspor, L., Kibbler, C. C., Faure, O., Biraghi, E., Canton, E., Zimmermann, K., Seaton, S., et al. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1103-y · Cited by 509
Epidemiological trends in nosocomial candidemia in intensive care
Bassetti, M., Righi, E., Costa, A., Fasce, R., Molinari, M. P., Rosso, R., Pallavicini, F. B., & Viscoli, C. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-21 · Cited by 332
Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies
Falagas, M. E., Apostolou, K. E., & Pappas, V. D. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0159-2 · Cited by 294
Self-citationPfaller, M. A., Jones, R. N., Doern, G. V., Sader, H. S., Hollis, R. J., Messer, S. A., & Group, F. T. S. P. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.7.1886-1889.1998 · Cited by 281
Viudes, A., Pemán, J., Cantón, E., Úbeda, P., López-Ribot, J., & Gobernado, M. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-002-0822-1 · Cited by 250
Cited by
Items 101–188 of 188
de Santana, M. M. P., Hoffmann‐Santos, H. D., Dias, L. B., Tadano, T., Karhawi, A. S. K., Dutra, V., Cândido, S. L., & Hahn, R. C. (2019) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2019.04.006 · Cited by 21
Candidaemia in Central Slovenia: A 12‐year retrospective survey
Matos, T., Zupanc, T. L., Škofljanec, A., Jazbec, A., Matos, E., Vodičar, P. M., Germ, J., Ciglar, T., Tomazin, R., Kofol, R., et al. (2021) · Mycoses · doi:10.1111/myc.13278 · Cited by 15
Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis
Xin, H., Glee, P. M., Adams, A., Mohiuddin, F., & EBERLE, K. E. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.03.061 · Cited by 18
Chen, X., Shen, M., Feng, Q., Yang, G., Tian, R., Yao, S., & Zha, H. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11021-2 · Cited by 17
“Conversely, other studies have indicated that mortality rate of bloodstream infections due to non-C. albicans was higher than that in C. albicans [18].”
Candida spondylodiscitis: a systematic review and meta-analysis of seventy two studies
Adelhoefer, S. J., Gonzalez, M. R., Bedi, A. D. S., Kienzle, A., Bäcker, H. C., Andronic, O., & Karczewski, D. C. (2023) · International Orthopaedics · doi:10.1007/s00264-023-05989-2 · Cited by 18
“Preliminary findings indicate that Candida spondylodiscitis affects high-risk cohorts, including those with prior IV drug abuse, obesity, and diabetes, oftentimes resulting in fatal outcomes [6, 7].”
BackgroundKarthaus, M., Rüping, M. J. G. T., Cornely, O. A., Steinbach, A., Groll, A. H., Lass‐Flörl, C., Ostermann, H., Ruhnke, M., & Vehreschild, J. J. (2011) · Mycoses · doi:10.1111/j.1439-0507.2010.01988.x · Cited by 14
Jakab, Á., Emri, T., Sipos, L., Kiss, Á., Kovács, R., Dombrádi, V., Kemény‐Beke, Á., Balla, J., Majoros, L., & Pócsi, I. (2015) · Journal of Basic Microbiology · doi:10.1002/jobm.201400903 · Cited by 17
Garnacho‐Montero, J., Díaz‐Martín, A., & Cayuela, A. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70015-3 · Cited by 12
“In fact, a recent study highlighted the high mortality associated with episodes of non-albicans species candidaemia, which was an independent risk factor for death in the multivariate analysis [27].”
Background(2014) · Journal of Vaccines & Vaccination · doi:10.4172/2157-7560.1000241 · Cited by 11
Marchena‐Gómez, J., Saez‐Guzman, T., Hemmersbach‐Miller, M., Martel, A. C., León, V. M., Benítez, A. B., & Acosta‐Mérida, M. A. (2009) · World Journal of Surgery · doi:10.1007/s00268-009-0120-5 · Cited by 13
“Regarding non-albicans Candida, glucocorticosteroids, central venous catheter placements, and pre-existing candiduria have been reported to be independently associated with candidemia due to nonalbicans Candida [13].”
BackgroundResultvan der Geest, P. J., Hunfeld, N., Ladage, S. E., & Groeneveld, A. B. J. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1825-3 · Cited by 12
Lakner, A., Essig, A., Frickmann, H., & Poppert, S. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02154.x · Cited by 11
Management of Multidrug-Resistant Infections in Cirrhosis
Gallaher, C., & Shawcross, D. L. (2022) · Seminars in Liver Disease · doi:10.1055/a-1765-0056 · Cited by 10
Wang, H., Wu, D., Han, H., Yue, J.-F., Zhang, F., Shan, T., Guo, H., & Yin, M. (2014) · Saudi Medical Journal · doi:10.15537/1658-3175.5900 · Cited by 12
Echinocandins in invasive candidiasis
Simon, J., Sun, H., Leong, H. N., Barez, M. Y., Huang, P., Talwar, D., Wang, J.-H., Mansor, M. M., Wahjuprajitno, B., Patel, A. K., et al. (2013) · Mycoses · doi:10.1111/myc.12085 · Cited by 12
Antibiotic Overuse as a Risk Factor for Candidemia in an Indian Pediatric ICU
Agrawal, C. K., Biswas, D., Gupta, A., & Chauhan, B. S. (2014) · The Indian Journal of Pediatrics · doi:10.1007/s12098-014-1631-0 · Cited by 10
Panpetch, W., Tumwasorn, S., & Leelahavanichkul, A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309106 · Cited by 11
Update: invasive Pilzinfektionen: Diagnose und Therapie in der operativen Intensivmedizin
Lichtenstern, C., Swoboda, S., Hirschburger, M., Domann, E., Hoppe‐Tichy, T., Winkler, M., Lass‐Flörl, C., & Weigand, M. A. (2010) · Der Anaesthesist · Cited by 9
Update: invasive Pilzinfektionen
Lichtenstern, C., Swoboda, S., Hirschburger, M., Domann, E., Hoppe‐Tichy, T., Winkler, M., Lass‐Flörl, C., & Weigand, M. A. (2010) · Der Anaesthesist · doi:10.1007/s00101-009-1655-4 · Cited by 12
Candidemia in the pediatric intensive care unit in Eastern India
Mishra, R., Behera, C. K., Jena, P., Mishra, S. N., Sahoo, B., Patnaik, S., & Jain, M. K. (2020) · JOURNAL OF PEDIATRIC CRITICAL CARE · doi:10.4103/jpcc.jpcc_38_20 · Cited by 12
Kord, M., Salehi, M., Hashemi, S. J., Abdollahi, A., Alijani, N., Maleki, A., Mahmoudi, S., Ahmadikia, K., Parsameher, N., Moradi, M., et al. (2022) · Current Medical Mycology · doi:10.18502/cmm.8.3.11207 · Cited by 14
Rapid identification of yeast by fluorescence in situ hybridisation from broth and blood cultures
Frickmann, H., Lakner, A., Essig, A., & Poppert, S. (2012) · Mycoses · doi:10.1111/j.1439-0507.2012.02214.x · Cited by 9
Fulminant, Undetected Candida Sepsis After an Apparently Survivable Burn Injury
Struck, M. F., Stiller, D., Corterier, C. C., Reichelt, B., & Steen, M. (2009) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e3181b48794 · Cited by 8
Karadağ, F. Y., Ergen, P., Aydın, Ö., Doğru, A., Berrin, T., & VAHABOĞLU, M. H. (2016) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1505-70 · Cited by 8
Kahramanmaras Afsin Devlet Hastanesi, I. H. V. K. M. K., Kolak, C. C., Daloğlu, A. E., Özhak, B., Öğünç, D., & Günseren, F. (2020) · Klimik Dergisi/Klimik Journal · doi:10.5152/kd.2019.71 · Cited by 10
Gangneux, J., Cornet, M., Bailly, S., Fradin, C., Féger, C., Timsit, J., Leroy, O., Sendid, B., & Bougnoux, M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02907 · Cited by 8
“However, in studies with a clinical set of data sufficiently detailed for conducting multivariable logistic regression, findings are variable, some identifying a higher independent risk of death for candidemia due to non-albicans species (Dimopoulos et al., 2008; Lortholary et al., 2014), while the species of the Cand…”
BackgroundSandoval‐Denis, M., Pastor, F. J., Capilla, J., Sutton, D. A., Fothergill, A. W., & Guarro, J. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.10.024 · Cited by 10
Liu, F., Shao, X., Dong, Z., Tang, K., Zhong, L., Xu, W., Chen, Z., Zheng, C., Zhang, K., Cai, J., et al. (2023) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-023-04672-z · Cited by 7
Economic considerations of antifungal prophylaxis in patients undergoing surgical procedures
Petrosillo, N., & Cataldo, A. (2011) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s11895 · Cited by 9
Voriconazole and posaconazole therapy for experimental Candida lusitaniae infection
Sanchis, M., Guarro, J., Sutton, D. A., Fothergill, A. W., Wiederhold, N. P., & Capilla, J. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.09.010 · Cited by 11
“Candida lusitaniae is an emerging opportunistic nosocomial pathogen causing candidemia with attributed incidence around 1–2% (Atkinson et al., 2008; Dimopoulos et al., 2008).”
BackgroundAn Update on the Epidemiology of Candidemia in Children
Dutta, A., Zaoutis, T. E., & Palazzi, D. L. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0113-y · Cited by 8
Tahtler, J. G., Cicvarić, A., Koulenti, D., Karvouniaris, M., Bogdan, M., Kralik, K., Kmoniček, I. K., Grbić, M., & Kvolik, S. (2024) · Journal of Fungi · doi:10.3390/jof10110743 · Cited by 10
Yamin, D., Wakil, A. M., Goni, M. D., Irekeola, A. A., & Hajissa, K. (2025) · Asian Pacific Journal of Tropical Medicine · doi:10.4103/apjtm.apjtm_559_24 · Cited by 8
The First Korean Case of Candidemia due to Candida dubliniensis
Yu, N., Kim, H. R., & Lee, M. (2012) · Annals of Laboratory Medicine · doi:10.3343/alm.2012.32.3.225 · Cited by 6
“[3, 11, 12].”
Liposomal amphotericin B in critically ill paediatric patients
Sideri, G., Falagas, M. E., Grigoriou, M., Vouloumanou, E. K., Papadatos, J. H., Lebessi, E., & Kafetzis, D. A. (2011) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2011.01288.x · Cited by 7
Self-citationClinico-microbiological study of candidemia in a tertiary care hospital of southern part of India.
Banerjee, B., Saldanha, D., & Baliga, S. (2015) · PubMed Central · Cited by 12
Intravenous Catheter-Associated Candidemia due to Candida membranaefaciens: The First Iranian Case.
Âghili, S. R., Shokohi, T., Boroumand, M. A., Fesharaki, S. H., & Salmanian, B. (2015) · PubMed Central · Cited by 7
Durmuş, M., Kalkan, S., Karahan, S. G., Bıçakcıoğlu, M., Özdemir, N., GÜN, Z. Ü., & Özer, A. B. (2023) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2022-003673 · Cited by 5
Xin, H. (2022) · Journal of Cellular Immunology · doi:10.33696/immunology.4.130 · Cited by 5
Tworzenie biofilmu Candida na protezach głosowych Provox®2 oraz Provox Acti Valve
Nowak, M., & Kurnatowski, P. (2010) · Otolaryngologia Polska · doi:10.1016/s0030-6657(10)70587-4 · Cited by 3
Moazeni, M., Hedayati, M. T., Davari, A., Jafarzadeh, J., Nikmanesh, B., Hamidieh, A. A., Nabili, M., Abastabar, M., Ahmadi, N., & Al‐Hatmi, A. M. S. (2022) · Current Medical Mycology · doi:10.32598/cmm.2023.1372 · Cited by 6
“Candida colonization has been reported in up to 60% of critically ill pediatric patients after 4-7 days in the ICU [10-12].”
BackgroundGupta, R., Malik, A., Rizvi, M., & Ahmed, M. (2016) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2016.601118 · Cited by 4
“Candida colonization is referred to as a risk factor for developing invasive candidiasis (Dimopoulos et al. , 2008).”
Davari, A., Jafarzadeh, J., Hedayati, M. T., Shokohi, T., Abastabar, M., Nikmanesh, B., & Moazeni, M. (2022) · Current Medical Mycology · doi:10.18502/cmm.8.2.10329 · Cited by 4
“According to a previous study [19], body sites more prone to Candida colonization include the oral cavity and the skin surrounding catheters.”
BackgroundSpecies Distribution and Antifungal Susceptibilities of Candida Species Isolated From Blood Culture
Cılo, B. D. (2023) · Cureus · doi:10.7759/cureus.38183 · Cited by 8
“has been observed in recent years [7-10].”
Invasive candidiasis in critically ill patients
Kaaniche, F. M., Allela, R., Cherif, S., & Algia, N. B. (2016) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.tacc.2016.11.002 · Cited by 7
Emergence of non albicans Candida in a tertiary care hospital of north In-dia
Gill, M. K., Sharma, S., & Khanna, A. (2019) · Indian Journal of Microbiology Research · doi:10.18231/2394-5478.2018.0051 · Cited by 3
Maldonado, I., Canigia, L. F., Vivot, W., Domecq, P., Davel, G., & Córdoba, S. B. (2011) · PubMed · doi:10.1590/s0325-75412011000200010 · Cited by 6
Approach to Managing Febrile Patients in the ICU
Banerjee, D., & Bhosale, V. V. (2016) · General Medicine Open Access · doi:10.4172/2327-5146.1000274 · Cited by 3
Fluconazole Exposure and Selection for Candida Non-albicans
Vandijck, D. M., Blot, S. I., Vandekerckhove, L., & Vogelaers, D. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181896c22 · Cited by 3
Abdalal, S. A., Attallah, D. M., Mokhtar, J. A., Kaki, R., Niyazi, H. A., Niyazi, H. A., & Aldarmasi, M. A. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s514737 · Cited by 3
Antifungal Susceptibility of Oral Candida Species Isolated from Patients with Thalassemia Major
El-Shokry, M. (2017) · Journal of Bacteriology & Mycology Open Access · doi:10.15406/jbmoa.2017.05.00160 · Cited by 3
Analysis of the relationship between fluconazole consumption and non–C. albicans Candida infections
Tyczkowska-Sieroń, E., Gaszyński, W., Tyczkowski, J., & Głowacka, A. (2014) · Medical Mycology · doi:10.1093/mmy/myu053 · Cited by 2
Baran, N., Ismail, S. S., Yurtsever, S. G., Rahim, O., Güngör, S., Senel, Y., & Demirci, M. (2013) · African Journal of Microbiology Research · doi:10.5897/ajmr2013.5600 · Cited by 2
“Candida spp. differ between countries and hospitals (Pfaller et al., 2003; Dimopoulos et al., 2008).”
BackgroundBakri, M. M. (2011) · Otago University Research Archive (University of Otago) · Cited by 2
Fournier, P. (2011) · HAL · Cited by 5
Yılmaz, K., Demiray, T., Köroğlu, M., Hatipoğlu, H., Kılıç, Ü., Karabay, O., & Altındiş, M. (2020) · Mediterranean Journal of Infection Microbes and Antimicrobials · doi:10.4274/mjima.galenos.2019.2019.37 · Cited by 1
Selection for Candida Non-albicans spp. After Fluconazole Use
Dimopoulos, G., & Falagas, M. E. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181898761 · Cited by 1
Self-citationJiman-Fatani, A. A., Meawed, T. E., & El-Hossary, D. (2015) · The International Arabic Journal of Antimicrobial Agents · doi:10.3823/770 · Cited by 1
Zingg, W., Eggimann, P., & Pittet, D. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1367-1.00132-4 · Cited by 2
Probiotics in Invasive Candidiasis
Colombo, J., & Arena, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802189-7.00048-4 · Cited by 2
Sawyer, R., Chou, J., McLaren, G., & Cheng, A. W. (2022) · World Journal of Surgical Infection · doi:10.4103/wjsi.wjsi_13_22 · Cited by 1
Yeast central nervous system infection in a critically ill patient: a case report
Frantzeskaki, F. G., Diakaki, C., Rizos, M., Θεοδωρακοπούλου, Μ., Papadopoulos, P., Antonopoulou, A., Nikitas, N., Lignos, M., Brountzos, Ε., Velegraki, A., et al. (2014) · Journal of Medical Case Reports · doi:10.1186/1752-1947-8-253 · Cited by 1
“Introduction Invasive fungal infections are increasingly common in intensive care unit (ICU) patients and are associated with prolonged hospitalization duration and increased mortality [1].”
BackgroundSelf-citationSikora, M., Gołaś, M., Piskorska, K., & Swoboda‐Kopeć, E. (2015) · Postępy Mikrobiologii - Advancements of Microbiology · Cited by 5
Belvisi, V. (2012) · Prevention & Research · doi:10.11138/pr/2012.1.2.053 · Cited by 1
“with defined infectious episodes, and especially the detection of patterns of susceptibility to antifungals, is probably due to judicious use of azoles in the ICU considered (20-25).”
InfluentialAbabneh, M., Abu-Bdair, O. A., Mhaidat, N. M., & Almomani, B. A. (2017) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.8634 · Cited by 2
MICROBIOLOGICAL SPECTRE OF TERTIARY PERITONITIS AS A COMPONENT OF ITS DIAGNOSTICS AND TREATMENT
Fomin, P., Matviychuk, O. B., & Kornіychuk, O. (2017) · EUREKA Health Sciences · doi:10.21303/2504-5679.2017.00466 · Cited by 1
“Hospital-acquired infections, concomitant diseases and immunosuppression are one of the most potent risk factors of mortality [14].”
BackgroundBelotserkovskiy, B. Z., Гельфанд, Е. Б., Bykov, A. O., Mamontova, O. A., & Николаевич, П. Д. (2019) · Surgery and Oncology · doi:10.17650/2686-9594-2019-9-4-11-20 · Cited by 1
Detecting Invasive Fungal Disease in Surgical Patients: Utility of the (13)- β- d -Glucan Assay
Skubic, J. J., Taghavi, S., Castillo‐Angeles, M., Ramsis, R., Salim, A., & Askari, R. (2020) · Surgical Infections · doi:10.1089/sur.2019.247 · Cited by 2
“In addition, increasing use of life sustaining-therapies in the intensive care unit (ICU) has led to more nosocomial fungal infections [6,7].”
Bettio, G. D. S. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.82.2010.tde-20072012-155753 · Cited by 2
de Batista, G. C. M. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2009.tde-10022010-093505 · Cited by 4
Al-Sofyani, K. A., & Uddin, M. S. (2024) · Preprints.org · doi:10.20944/preprints202406.0898.v1
Pathogens in Severe Sepsis: New Paradigms for Fungi Treatment
Bassetti, M., & Mikulska, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-03519-7_11
Wong, S. F., & Mak, J. W. (2010) · Hybridoma · doi:10.1089/hyb.2010.0049
“albicans remains the most frequently encountered Candida in clinical practice, non-albicans infections have increased.((1,2)) Among the latter, C.”
Kappe, R., Fuchs, E., Gorges, A., & Rimek, D. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01588.x
Antifungal Susceptibility Testing and Therapy
Cuenca‐Estrella, M., & Rodríguez-Tudela, J. L. (2009) · Springer eBooks · doi:10.1007/978-3-642-03150-2_14
“Candida spp. are the fourth most common cause of bloodstream infections in the USA, but less so in Europe ( Dimopoulos et al. 2008; Forrest et al. 2008; Hachem et al. 2008).”
BackgroundBelvisi, Citton, R., Di Vincenzo, E., Melucci, A. D., Cosentino, C., & Mastroianni, C. M. (2012)
Update: invasive Pilzinfektionen Diagnose und Therapie in der operativen Intensivmedizin
Anaesthesiologie, K. F., Heidelberg, U., & Briegel, J. (2010)
Furtado, Z. V., & Dias, M. (2017) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2017/1183
Endovascular Infections and Endocarditis
Zingg, W., & Pittet, D. (2019) · Springer eBooks · doi:10.1007/978-1-4939-9034-4_15
Kothalawala, M., Jayaweera, J., Arunan, S., & Jayathilake, A. (2020) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pamic.1.2020.19
“A similar study conducted in the USA between 1995 and 2005 reported that the duration of fluconazole treatment and central venous catheterization are significant risk factors for the development of candidemia [30].”
ResultAl-Sofyani, K. A., Uddin, M. S., Alghamdi, H. S., & El-Hossary, D. (2020) · Acta Scientific Paediatrics · doi:10.31080/aspe.2020.03.0318 · Cited by 1
Kord, M., Salehi, M., Hashemi, S. J., Rezaie, S., Maleki, A., Mahmoudi, S., Ahmadikia, K., Izadi, A., Abdollahi, A., Alijani, N., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-127871/v1
“In a prospective study performed in the ICU of a tertiary care hospital in Athens, the authors noted that the administration of glucocorticoids, presence of CVCs, and candiduria were independent risk factors for candidemia caused by NAC species [50].”
BackgroundChoudhary, A. K., Agnihotri, S., & Yadav, K. (2022) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/2406948
Liu, F., Zhong, L., Zhou, F., Zheng, C., Zhang, K., Cai, J., Zhou, H., Tang, K., Dong, Z., Cui, W., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-493061/v1
Differential dendritic cell responses to candida species
Yen, T. N. N., Ritprajak, P., & Matangkasombat, O. (2017) · Chula Digiverse · doi:10.58837/chula.the.2017.392
Metadata
- Authors
- Dimopoulos, G., Ntziora, F., Rachiotis, G., Armaganidis, A., & Falagas, M. E.
- Affiliations
- Alfa Institute of Biomedical Sciences (GR)
- Sotiria General Hospital (GR)
- University General Hospital Attikon (GR)
- Tufts University (US)
- Corresponding author
- Rachiotis, George
- Venue
- Anesthesia & Analgesia
- Published
- 2008-02
- Volume
- 106
- Issue
- 2
- Pages
- 523-529
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W1986442140
- Cited by
- 189
- References
- 44
- Citations by year
- 2025: 4 · 2024: 3 · 2023: 6 · 2022: 10 · 2021: 5 · 2020: 13 · 2019: 12 · 2018: 3 · 2017: 9 · 2016: 7 · 2015: 20 · 2014: 14 · 2013: 9 · 2012: 12
- FWCI
- 13.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Anesthesia & Analgesia (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- Candida albicans, candidemia, critically ill patients, risk factors, glucocorticoids, central venous catheters, candiduria, Candida glabrata, Candida tropicalis, Candida parapsilosis, treatment response, mortality
- MeSH terms
- Aged, Aged, 80 and over, Candida albicans, Candidiasis, Cross Infection, Female, Glucocorticoids, Humans, Intensive Care Units, Male, Middle Aged, Prospective Studies, Risk Factors, Fungemia, Critical Illness, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.